Interphex: manufacturing product showcase
April 4, 2011Manufacturing and Production Interphex, PTI Inspection Systems, Pall Corp
This year’s Interphex exhibition in New York featured the usual crop of new product launches from processing and packaging equipment …
China’s new GMP rules will lead to industry consolidation
April 4, 2011Manufacturing and Production China, GMP
China’s new rules on Good Manufacturing Practice is likely to drive consolidation among the country’s 5,000-plus pharmaceutical companies, according to …
New BMS drug trumps peg-interferon alpha
April 4, 2011Research and Development, Sales and Marketing BMS, EASL, hepatitis C, pegintron alfa
Bristol-Myers Squibb has been given a boost by trial results which suggest its compound for hepatitis C, PEG-Interferon lambda, is …
Doubts cast on new Cancer Drugs Fund
April 1, 2011Cancer Drugs Fund, value-based pricing
There are stark regional variations in the number of doctors using the government’s provisional Cancer Drugs Fund, according to a …
Angela Pasma to lead Chiltern’s new Netherlands office
April 1, 2011Research and Development appointment, chiltern, research and development
Contract research organisation Chiltern has expanded its European operations, opening a new office in the Netherlands. The Leiden office will …
Amgen’s novel lung cancer drug disappoints in phase III
April 1, 2011Research and Development Amgen, Millennium, NSCLC, Takeda, motesanib, non-small cell lung cancer
Amgen’s lung cancer drug motesanib has not meet its primary endpoint in a phase III study. The drug, developed in …
GSK details $28.5m of research payments to US institutions
April 1, 2011Research and Development GSK, payments
GlaxoSmithKline has made public the payments it gave last year to US institutions engaged in clinical research on its behalf. …
TcL Pharma appoints French pharma veterans
April 1, 2011Research and Development, Sales and Marketing TcL, appointment, biotech, recruitment
TcL Pharma has appointed two seasoned veterans of the French pharmaceutical industry. Dr Jean-Hugues Masgnaux joins the French biotech company …
NHS reforms caught in a ‘reality gap’ as dissent grows
March 31, 2011Andrew Lansley, Liberating the NHS, NHS, NHS reform
The proposed NHS reforms are in danger of failing because of a ‘reality gap’ between the government’s ambitions for change …
AstraZeneca pays $1.1bn to resolve tax affairs
March 31, 2011Sales and Marketing AstraZeneca, tax
AstraZeneca has sorted out a decade-long dispute over its tax affairs by agreeing to pay out $1.1 billion this year. …
Valeant makes $5.7 billion hostile bid for Cephalon
March 31, 2011Research and Development, Sales and Marketing Cephalon, Valeant
Valeant has made a hostile bid for Cephalon, but analysts believe its offer is too low for the deal to …
Roche appoints Janet Hammond to translational medicine role
March 31, 2011Research and Development appointment, research and development
Janet Hammond has joined Roche to drive the early clinical development strategy for its virology discovery and translational area. She …
AZ’s Dr Yunxia Bi joins ISP
March 30, 2011Manufacturing and Production appointment, manufacturing and production
ISP Pharmaceuticals has appointed Dr Yunxia (Vivian) Bi as technical director of its solubility initiative. It is a newly-created position …
Merck re-submits Erbitux to the EMA for lung cancer
March 30, 2011Sales and Marketing EGFR, Erbitux, Iressa, Merck KGaA, NSCLC, Tarceva, lung cancer drugs, non-small cell lung cancer
Merck KGaA has re-submitted Erbitux’s lung cancer licence extension to the EMA after its first application to the regulator was …
Milburn adds his voice to growing disquiet on NHS reforms
March 30, 2011Alan Milburn, NHS, NHS reforms
Former Labour health secretary Alan Milburn has come out against the government’s health reforms, adding to the chorus of voices …
NHS Alliance: Social enterprises are future of public health services
March 30, 2011NHS, NHS Alliance, NHS reforms, Right to Request, public health services, social enterprise
The NHS Alliance has once more backed the idea that social enterprise should form the backbone of public health services …
New pharma skills needed for GP commissioning changes
March 30, 2011Business Services, Sales and Marketing NHS reforms, skills, training
With GP-led commissioning taking the NHS into new territory, market access is facing a major shake up. In January, one …
Dr Clive Deverson joins Photosound
March 30, 2011Medical Communications appointment, medical communications
Photosound has appointed Dr Clive Deverson as head of client strategy and medical communications. He joins the Hertfordshire, UK-based global …
EU Clinical Trials Register is Launched
March 29, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates
The European Medicines Agency (EMA) has announced the launch of its EU Clinical Trials Register. This online register allows public …
Roche changes raise Novartis takeover question
March 29, 2011Sales and Marketing Novartis, Roche, mergers and acquisitions
Roche could be vulnerable to a takeover from its Swiss rival Novartis after changes in its boardroom. The Roche family …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
